XTSE
BABY
Market cap3mUSD
Apr 04, Last price
0.02CAD
1D
0.00%
1Q
0.00%
IPO
-98.80%
Name
Else Nutrition Holdings Inc
Chart & Performance
P/E
—
P/S
0.46
EPS
—
Div Yield, %
—
Shrs. gr., 5y
34.58%
Rev. gr., 5y
%
Revenues
9m
+9.78%
Net income
-16m
L-11.38%
CFO
-18m
L-12.43%
Earnings
May 13, 2025
Profile
Else Nutrition Holdings Inc. engages in the development, production, and sale of food and nutrition products for infants, toddlers, children, and adults in North America and Israel. It offers baby snacks; baby feeding accessories, such as feeding bottles and teats; plant-based baby formula products; toddler, children, and adult nutrition products; and complementary food products. The company also offers its products through online. Else Nutrition Holdings Inc. is headquartered in Tel Aviv-Yafo, Israel.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
| Income | ||||||||||
Revenues | 9,361 9.78% | 8,527 81.93% | ||||||||
Cost of revenue | 23,657 | 25,443 | ||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (14,296) | (16,916) | ||||||||
NOPBT Margin | ||||||||||
Operating Taxes | (2,921) | |||||||||
Tax Rate | ||||||||||
NOPAT | (14,296) | (13,995) | ||||||||
Net income | (15,609) -11.38% | (17,614) 988.63% | ||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 4,394 | 6,743 | ||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | 194 | 238 | ||||||||
Long-term debt | 3,200 | 3,685 | ||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 3,283 | 4,072 | ||||||||
Net debt | (1,531) | (11,458) | ||||||||
| Cash flow | ||||||||||
Cash from operating activities | (18,311) | (20,911) | ||||||||
CAPEX | (160) | |||||||||
Cash from investing activities | (1,126) | 170 | ||||||||
Cash from financing activities | 7,443 | 11,689 | ||||||||
FCF | (14,885) | (16,047) | ||||||||
| Balance | ||||||||||
Cash | 4,925 | 15,381 | ||||||||
Long term investments | ||||||||||
Excess cash | 4,457 | 14,955 | ||||||||
Stockholders' equity | 6,721 | 10,804 | ||||||||
Invested Capital | 8,638 | 12,228 | ||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | 129,779 | 108,685 | ||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | (13,917) | (16,420) | ||||||||
EV/EBITDA | ||||||||||
Interest | 63 | 13 | ||||||||
Interest/NOPBT | ||||||||||